Hepatic Steatosis and Steatohepatitis Is the Inevitability of Mixed Genesis

Hepatic Steatosis and Steatohepatitis Is the Inevitability of Mixed Genesis

The analysis of the etiological and pathogenetic mechanisms of formation steatosis and steatohepatitis of mixed genesis is presented. It is shown that alcohol remains one of the main etiopathogenetic factors in the development of the hepatic steatosis and steatohepatitis, the role of which is observ...

Full description

Bibliographic Details
Main Author:	Yu.M. Stepanov
Format:	Article
Language:	English
Published:	Zaslavsky O.Yu. 2014-11-01
Series:	Gastroenterologìa
Subjects:	steatosis steatohepatitis alcohol obesity insulin resistance etiopathogenesis diagnosis correction
Online Access:	http://gastro.zaslavsky.com.ua/article/view/82089

Similar Items

Metabolic preconditions for the formation and progression of steatohepatitis of alcoholic, mixed, non-alcoholic aetiology and their comorbidity with obesity and anaemic conditions
by: T. Antofiichuk, et al.
Published: (2023-05-01)

Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis
by: Nancy Magee, et al.
Published: (2022-12-01)

Obesity-related non-alcoholic steatohepatitis and TGF-β1 serum levels in relation to morbid obesity
by: Ricardo N Sepúlveda-Flores, MD, et al.
Published: (2002-01-01)

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
by: Janet Sánchez-Quevedo, et al.
Published: (2022-09-01)

Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story
by: Mauro Cataldi, et al.
Published: (2021-11-01)

Insulin resistance and the metabolic syndrome are related to the severity of steatosis in the pediatric population with obesity
by: Esther Ubiña-Aznar, et al.

REVIEW PAPER<br>Non-alcoholic steatohepatitis (NASH)
by: János Fehér, et al.
Published: (2005-04-01)

SENSITIVITY AND SPECIFICITY OF VECTORCARDIOGRAPHY IN DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION COMORBID WITH LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS
by: I. E. Belaya, et al.
Published: (2015-12-01)

Steatosis and steatohepatitis found in adults after death due to non-burn trauma
by: Paulo Reis-Júnior, et al.
Published: (2019-10-01)

Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
by: Ting-Chen Chang, et al.
Published: (2019-12-01)

Chemotherapy-associated steatohepatitis
by: Lucy Meunier, et al.
Published: (2020-11-01)

MONOCYTE/HDL RATIO IN NON-ALCOHOLIC HEPATIC STEATOSIS
by: Ahmet YOZGAT, et al.
Published: (2021-12-01)

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
by: Ludovico Abenavoli, et al.
Published: (2021-02-01)

Non-alcoholic Steatohepatitis: An Overview
by: Allison Shifflet, et al.
Published: (2009-01-01)

Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of Steatohepatitis
by: Rishi R. Bhardwaj, et al.
Published: (2010-03-01)

Irinotecan-Induced Steatohepatitis: Current Insights
by: Jun Han, et al.
Published: (2021-10-01)

Pathohistological characteristics of steatohepatitis on needle biopsy sample from 100 patients
by: Milićević Anđela, et al.
Published: (2019-01-01)

Pancreatic steatosis in children. Part 1. Etiology, epidemiology and pathogenesis
by: Yu.M. Stepanov, et al.
Published: (2017-02-01)

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
by: Serena Scapaticci, et al.
Published: (2021-04-01)

Angiogenesis in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: Gavrilyuk O.M.
Published: (2013-12-01)

Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice
by: Giovanni Enrico Lombardo, et al.
Published: (2018-03-01)

Liver ultrasound scanning in the detection of hepatic steatosis and fibrosis in NASH patients
by: Mona Hegazy, et al.
Published: (2012-01-01)

Novel Approaches in the Management of Type 2 Diabetes and Associated Vascular Complications
by: K. V. S. Hari Kumar
Published: (2021-06-01)

Trans-Fatty Acids Aggravate Obesity, Insulin Resistance and Hepatic Steatosis in C57BL/6 Mice, Possibly by Suppressing the IRS1 Dependent Pathway
by: Xiaona Zhao, et al.
Published: (2016-05-01)

Insulin resistance and steatosis in chronic hepatitis C
by: Mariana V. Machado, et al.
Published: (2009-01-01)

Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis
by: Cristina Alarcón-Vila, et al.
Published: (2023-02-01)

Targeting MRG15 for the treatment of nonalcoholic steatohepatitis
by: Yao Zhang, et al.
Published: (2022-12-01)

Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
by: Teresa Auguet, et al.
Published: (2014-12-01)

p62/Sqstm1 rescue in muscle retards the progression of steatohepatitis in p62/Sqstm1-null mice fed a high-fat diet
by: Ikuru Miura, et al.
Published: (2022-11-01)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01)

Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitis
by: Xiaoya Li, et al.
Published: (2022-10-01)

The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials
by: Ioana-Cristina Bica, et al.
Published: (2023-06-01)

FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
by: Erik J. Tillman, et al.
Published: (2020-12-01)

Hepatitis C and insulin resistance: steatosis, fibrosis and non-response Hepatitis C y resistencia a la insulina: esteatosis, fibrosis y no respuesta
by: M. Romero-Gómez
Published: (2006-08-01)

Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
by: Sandra Torres, et al.
Published: (2022-04-01)

miR-378b Regulates Insulin Sensitivity by Targeting Insulin Receptor and p110α in Alcohol-Induced Hepatic Steatosis
by: Yuan-yuan Li, et al.
Published: (2020-05-01)

Risk Factors for Hepatic Steatosis in Children
by: Yu.M. Stepanov, et al.
Published: (2016-04-01)

Correlation between red cell distribution width and grade of hepatic steatosis and liver enzymes in patients with Non-Alcoholic steatohepatitis
by: Ali Dogan, et al.
Published: (2018-03-01)

Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
by: Clarissa Berardo, et al.
Published: (2020-12-01)

Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway
by: Yan Yang, et al.
Published: (2024-03-01)